{
  "questions": [
    {
      "question": "What is the empirical formula of the synthesized [((S)-ibuprofen)3UO2][Na] complex?",
      "answer": "C41.11H56.07NaO8U",
      "difficulty": "easy",
      "type": "factual"
    },
    {
      "question": "What technique was used to measure the quantum yield of the [((S)-ibuprofen)3UO2][Na] complex under UV excitation?",
      "answer": "The quantum yield was measured by the relative method using 9,10-diphenylanthracene as a standard.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "How does the radiative lifetime of the [((S)-ibuprofen)3UO2][Na] complex change when excited at 280 nm compared to 450 nm?",
      "answer": "The radiative lifetime at 480 nm is 4.44 μs (± 0.1) under 280 nm excitation and 4.96 μs (± 0.4 μs) under 450 nm excitation.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: The circularly polarized luminescence (CPL) spectra of the [((S)-ibuprofen)3UO2][Na] complex were collected using a bandpass of 13 nm.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What was the method used for the enantiomeric resolution of racemic ibuprofen?",
      "answer": "Enantiopure (R)- and (S)- ibuprofen were resolved by an adaptation of a previously reported procedure using (R)-α-phenylethylamine and (S)-α-phenylethylamine.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "What is the significance of the Flack parameter in the XRD structural refinement parameters for [((S)-ibuprofen)3UO2][Na]?",
      "answer": "The Flack parameter is used to determine the absolute configuration of chiral molecules in crystal structures. A value close to 0 or 1 indicates a pure enantiomer.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: The luminescence decay curves of the [((S)-ibuprofen)3UO2][Na] complex were collected with fixed emission monitoring at 480 nm after excitation at 295 nm.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What was the observed phenomenon when the [((S)-ibuprofen)3UO2][Na] complex was titrated with cyclohexylacetic acid?",
      "answer": "The fluorescence of the complex was quenched upon titration with cyclohexylacetic acid, indicating ligand dissociation.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "True or False: The CPL spectra of the [((S)-ibuprofen)3UO2][Na] complex under UV excitation were collected using a 45º cell orientation.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What was the purpose of using 2-methyl THF in the low-temperature (77 K) normalized emission spectrum of the (S)- complex?",
      "answer": "2-methyl THF was used to obtain a glass suitable for photophysical measurements at low temperatures.",
      "difficulty": "medium",
      "type": "reasoning"
    }
  ]
}
